首页> 外文OA文献 >Safety and efficacy of tipranavir co-administered with low-dose ritonavir in patients with advanced HIV-1 infection and limited treatment options

【2h】

Safety and efficacy of tipranavir co-administered with low-dose ritonavir in patients with advanced HIV-1 infection and limited treatment options

机译：替普那韦与小剂量利托那韦合用对晚期HIV-1感染和治疗选择有限的患者的安全性和有效性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2008
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Long-Term Efficacy, Tolerability, and Renal Safety of Atazanavir/Ritonavir-based Antiretroviral Therapy in a Cohort of Treatment-Naive Patients with HIV-1 Infection: the REMAIN Study [J] . Teofilo Eugenio, Rocha-Pereira Nuno, Kuhlmann Birger, HIV clinical trials . 2016,第1期

机译：一项尚无治疗的未接受过HIV-1感染的患者队列中基于Atazanavir / Ritonavir的抗逆转录病毒疗法的长期疗效，耐受性和肾脏安全性
2. Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials. [J] . Clotet B, Bellos N, Molina JM, The Lancet . 2007,第9568期

机译：在POWER 1和2中接受治疗的HIV-1感染患者中达那那韦-利托那韦在第48周的疗效和安全性：来自两项随机试验的数据的汇总亚组分析。
3. Pharmacokinetics, Safety, and Efficacy of Tipranavir Boosted With Ritonavir Alone or in Combination With Other Boosted Protease Inhibitors as Part of Optimized Combination Antiretroviral Therapy in Highly Treatment-Experienced Patients (BI Study 1182 [J] . Walmsley SL, Katlama C, Lazzarin A, JAIDS: Journal of acquired immune deficiency syndromes . 2008,第4期

机译：高度利于治疗的患者中，单独使用利托那韦或与其他增强的蛋白酶抑制剂联用的替普那韦的药代动力学，安全性和有效性，作为优化组合抗逆转录病毒疗法的一部分（BI研究1182）
4. Efficacy and Safety of Polymyxin B in the Treatment of Infections Caused by Multidrug- Resistant Gram-Negative Infections: A Retrospective Review [C] . Oh HML, Gan LH, Wee I International Congress of Chemotherapy and Infection . 2009

机译：多种抗革兰阴性感染治疗感染治疗感染的疗效和安全性：回顾性综述
5. Safety assessment of tipranavir: A protease inhibitor treatment for HIV infected adults. [D] . Mikl, Jaromir. 2010

机译：替普那韦的安全性评估：蛋白酶抑制剂治疗的艾滋病毒感染成年人。
6. Efficacy and safety of darunavir (Prezista®) with low-dose ritonavir and other antiretroviral medications in subtype F HIV-1 infected treatment-experienced subjects in Romania: a post-authorization open-label one-cohort non-interventional prospective study [O] . Otilia Elisabeta Benea, Adrian Streinu-Cercel, Carmen Dorobăţ, 2014

机译：darunavir（Prezista®）与小剂量利托那韦和其他抗逆转录病毒药物在F型HIV-1亚型感染治疗经验丰富的罗马尼亚患者中的疗效和安全性：授权后开放标签单队列非干预前瞻性研究
7. Safety and efficacy of tipranavir co-administered with low-dose ritonavir in patients with advanced HIV-1 infection and limited treatment options [O] . Esser S, Moll A, Cairns V, 2008

机译：替拉那韦与晚期HIV-1感染和有限治疗选择的患者共同使用低剂量利托那韦的安全性和有效性

Safety and efficacy of tipranavir co-administered with low-dose ritonavir in patients with advanced HIV-1 infection and limited treatment options

著录项

引文网络

相似文献

相关主题

期刊订阅